Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 11.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 004F37 | Andrew G. Riedl [Royaume-Uni] ; Paul M. Watts [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | P450 enzymes and Parkinson's disease: The story so far |
| 005034 | Ronald K. B. Pearce [Royaume-Uni] ; Tara Banerji [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | De novo administration of ropinirole and bromocriptine induces less dyskinesia than L‐dopa in the MPTP‐treated marmoset |
| 005355 | Lance A. Smith ; Ariel Gordin ; Jenner [Finlande] ; C. David Marsden [Royaume-Uni] | Entacapone enhances levodopa‐induced reversal of motor disability in MPTP‐treated common marmosets |
| 005582 | G. K. Wenning [Royaume-Uni] ; R. Granata [Italie] ; P. M. Laboyrie ; N. P. Quinn [Royaume-Uni] ; Jenner ; C. D. Marsden [Royaume-Uni] | Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration |
| 005599 | B. Zeng [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6‐Hydroxydopamine–Lesioned rat striatum parallels functional recovery |
| 005710 | Lance Smith [Royaume-Uni] ; Maria De Salvia [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | An appraisal of the antiparkinsonian activity of piribedil in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmosets |
| 005921 | R. K. B. Pearce ; M. Jackson ; L. Smith ; Jenner ; C. D. Marsden [Royaume-Uni] | Chronic L‐DOPA administration induces dyskinesias in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmoset (Callithrix jacchus) |
| 005B65 | David T. Dexter [Royaume-Uni] ; Anne E. Holley ; William D. Flitter ; Trevor F. Slater ; F. Raymund Wells [Royaume-Uni] ; Susan E. Daniel [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study |
| 005C02 | S. Rose [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Chronic administration does not alter the accumulation of L‐dopa into muscle |
| 005D25 | S. B. Blunt [Royaume-Uni] ; Jenner ; C. D. Marsden [Royaume-Uni] | Suppressive effect of L‐dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6‐hydroxydopamine |
| 006443 | D. T. Dexter [Royaume-Uni] ; Jenner [Royaume-Uni] ; Marsden [Royaume-Uni] | Oxyferriscorbone elevates the total iron content of blood but not brain |
| This area was generated with Dilib version V0.6.23. |  |